Pharmaceutical companies would never launch a new product without having a compensation plan in place for their sales representatives. But until now, companies have had to launch new indications for existing drugs without the ability to compensate the sales reps who are most effective at marketing the indication, and better coach reps who are less effective. Verispan solves this problem with Vector One(TM): Indication, the first syndicated product that brings together robust prescription and diagnosis information to enable indication-specific sales compensation at the territory level.
